CRWV
CoreWeave, Inc. Class A Common Stock
CRWV has a slight edge over QCOM overall, supported by stronger modeled upside.
QCOM
QUALCOMM Incorporated
QCOM has slightly lower modeled downside risk, despite its lower overall score.
CRWV Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Strong |
CRWV's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.
QCOM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Healthy |
QCOM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CRWV PE Valuation
CRWV has no meaningful PE right now: it lost money over the past year.
QCOM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $175 | -1.1% |
| Current | 14x | $177 | — |
| Fair | 20x | $248 | +40% |
| Expensive | 26x | $333 | +88% |
Historical ranges are pointers, not guarantees.
QCOM's PE is in its cheap range at 14x.
CRWV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect CRWV's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
QCOM Forward outlook
There aren't enough analyst estimates for QCOM to show an outlook.
CRWV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.31 | -$1.83 |
| Q2 2026 | -$3.26 | -$0.16 |
| Q1 2026 | -$2.72 | +$0.62 |
| Q4 2025 | -$2.81 | -$0.64 |
| Q3 2025 | -$2.48 | -$0.06 |
CRWV lost $4.31 per share over the past year, a bigger loss than the year before.
QCOM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $12.70 | +153% |
| Q2 2026 | $8.76 | -15% |
| Q1 2026 | $9.32 | -4.9% |
| Q4 2025 | $4.96 | -47% |
| Q3 2025 | $5.01 | -44% |
| Q2 2025 | $10.35 | +34% |
| Q1 2025 | $9.80 | +32% |
| Q4 2024 | $9.34 | +35% |
QCOM has the edge over CRWV on earnings quality, reporting a profit while its opponent remains loss making.
CRWV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +168% |
| Q2 2026 | $2.6B | +112% |
| Q1 2026 | $2.1B | +112% |
| Q4 2025 | $1.6B | +110% |
| Q3 2025 | $1.4B | +134% |
| Q2 2025 | $1.2B | +207% |
| Q1 2025 | $981.6M | +420% |
| Q4 2024 | $747.4M | +544% |
CRWV has the edge over QCOM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | +1.9 points |
| Q2 2026 | -1.9% | -3.5 points |
| Q1 2026 | -6.9% | -4.1 points |
| Q4 2025 | -5.7% | -21 points |
| Q3 2025 | 3.8% | -16 points |
| Q2 2025 | 1.6% | -18 points |
| Q1 2025 | -2.8% | -12 points |
| Q4 2024 | 15% | +17 points |
CRWV's operating margin was 5.7% last quarter, up 1.9 points from the same quarter a year ago.
QCOM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.3B | -8.4% |
| Q2 2026 | $9.9B | -4% |
| Q1 2026 | $10.6B | -3.5% |
| Q4 2025 | $12.3B | +5% |
| Q3 2025 | $11.3B | +10% |
| Q2 2025 | $10.4B | +10% |
| Q1 2025 | $11B | +17% |
| Q4 2024 | $11.7B | +17% |
QCOM's revenue grew through 2024 and has held roughly level since: $10.3B last quarter, down 8.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | -13 points |
| Q2 2026 | 16% | -10 points |
| Q1 2026 | 22% | -6.6 points |
| Q4 2025 | 27% | -3 points |
| Q3 2025 | 26% | +0.7 points |
| Q2 2025 | 27% | +3 points |
| Q1 2025 | 28% | +3.5 points |
| Q4 2024 | 30% | +1 points |
QCOM has the edge over CRWV on profitability, with a higher operating margin.
CRWV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.5B | -$6.8B |
| Q2 2026 | -$5.7B | -$3B |
| Q1 2026 | -$4.7B | -$3.4B |
| Q4 2025 | -$2.5B | +$810.3M |
| Q3 2025 | -$699.8M | -$125.8M |
| Q2 2025 | -$2.7B | -$339.3M |
| Q1 2025 | -$1.3B | -553% |
| Q4 2024 | -$3.3B | -$2.2B |
CRWV has burned cash in almost every quarter: −$20.4B over the past year, against −$8.1B the year before.
QCOM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.8B | -49% |
| Q2 2026 | $495M | -81% |
| Q1 2026 | $1.9B | -18% |
| Q4 2025 | $4.4B | +2.5% |
| Q3 2025 | $3.6B | +50% |
| Q2 2025 | $2.6B | -3.2% |
| Q1 2025 | $2.3B | -31% |
| Q4 2024 | $4.3B | +58% |
QCOM has the edge over CRWV on cash generation, producing positive trailing cash flow while its opponent burns cash.
CRWV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +8M shares |
| 1 year | +12% | +61.1M shares |
CRWV has 559M diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | $1.5M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $32.1M |
QCOM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +4M shares |
| 1 year | -2.9% | -32M shares |
| 3 years | -4.7% | -53M shares |
| 5 years | -6.6% | -76M shares |
| Available history | -7.4% | -86M shares |
QCOM has the edge over CRWV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1B |
| Q2 2026 | $1.4B |
| Q1 2026 | $2.8B |
| Q4 2025 | $2.7B |
| Q3 2025 | $2.4B |
| Q2 2025 | $2.8B |
| Q1 2025 | $1.7B |
| Q4 2024 | $1.8B |
QCOM spent $7.8B buying back its own shares over the past year, down 11% from the year before.
CRWV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | 7.6x | High |
| Q4 2025 | 7.6x | High |
| Q3 2025 | 5.6x | High |
| Q2 2025 | 6.5x | High |
| Q1 2025 | 8.4x | High |
| Q4 2024 | 19.3x | High |
CRWV has the edge over QCOM on leverage, with a lower net debt burden relative to earnings.
QCOM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.0x | Healthy |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
QCOM's net debt is about a year of its operating earnings (EBITDA), up from less than a year a year ago.
CRWV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.7 | Neutral |
| Stochastic | 11.3 | Oversold |
CRWV's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
QCOM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 40.2 | Neutral |
QCOM's weekly RSI is 51 (neutral) and its Stochastic is 40 (neutral).
CRWV PE vs Technology Sector
CRWV has no meaningful PE right now: it lost money over the past year.
QCOM PE vs Technology Sector
| Metric | QCOM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 50% below |
| PE % | 17 | 35 | 18 pts below |
QCOM is trading at 14x earnings, a 50% discount to the Technology sector's median of 28x.
CRWV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.6 | 15% below |
| 20 week MA | $77.4 | 27% below |
| 50 week MA | $87.4 | 35% below |
QCOM has stronger trend alignment. CRWV is above 0 of 3 weekly averages versus QCOM above 4 of 5.
QCOM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $177.2 | 0% below |
| 20 week MA | $172.8 | 2.5% above |
| 50 week MA | $170.7 | 3.8% above |
| 100 week MA | $164.3 | 7.8% above |
| 200 week MA | $155.1 | 14% above |
QCOM's trend is up, with a small recent dip: it's below only its 8-week average, and 14% above its 200-week average.
CRWV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $40.0 | $76.4 | +91% |
| 2026 YTD | $76.4 | $56.6 | -26% |
CRWV has finished every year since 2025 higher, and it's down 26% so far in 2026.
QCOM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $88.8 | $148.8 | +68% |
| 2021 | $148.8 | $182.7 | +23% |
| 2022 | $182.7 | $110.8 | -39% |
| 2023 | $110.8 | $144.6 | +30% |
| 2024 | $144.6 | $157.2 | +8.7% |
| 2025 | $157.2 | $174.8 | +11% |
| 2026 YTD | $174.8 | $177.1 | +1.3% |
QCOM has the edge over CRWV on returns for 2026, with the stronger performance.